FRANKFURT--The following is a summary of analysts' forecasts for
Merck KGaA (MRK.XE) fourth-quarter results, based on a poll of 10
analysts conducted by Dow Jones Newswires (figures in million
euros, EPS, dividend and target price in euro, according to IFRS).
Earnings figures are scheduled to be released March 3.
===
Total EBITDA
4th Quarter revenue(a) Sales EBIT (b)
AVERAGE 2,935 2,909 477 853
Prev. Year 2,742 2,636 264 795
+/- in % +7.0 +10 +80 +7.2
MEDIAN 2,955 2,909 472 856
Maximum 2,983 2,947 516 873
Minimum 2,828 2,861 448 811
Amount(c) 9 6 5 10
Baader-Helvea 2,955 2,912 -- 873
Barclays 2,919 2,888 516 870
Berenberg 2,955 2,906 472 840
Commerzbank 2,983 -- 469 870
Deutsche Bank 2,981 2,947 448 859
Equinet 2,828 -- -- 855
Independent Research 2,940 -- -- 854
Morgan Stanley -- 2,938 -- 857
Warburg Research 2,955 -- -- 811
Net attrib. EPS
4th Quarter income (b)
AVERAGE 297 1.11
Prev. Year 281 1.06
+/- in % +5.7 +5.0
MEDIAN 310 1.12
Maximum 314 1.18
Minimum 268 1.00
Amount(c) 5 8
Baader-Helvea -- 1.00
Barclays -- 1.10
Berenberg 310 1.15
Commerzbank 310 1.10
Deutsche Bank 268 1.14
Morgan Stanley -- 1.18
Warburg Research 281 1.12
Target price Rating DPS 2014
AVERAGE 84.94 positive 2 AVERAGE 1.03
Prev. Quarter 73.69 neutral 6 Prev. Year 0.95
+/- in % +15 negative 2 +/- in % +8.2
MEDIAN 84.00 MEDIAN 1.05
Maximum 105.00 Maximum 1.05
Minimum 66.50 Minimum 0.95
Amount 9 Amount 6
Baader-Helvea 89.00 Hold --
Barclays 84.00 Equalweight 1.02
Berenberg 90.00 Hold 0.95
Commerzbank 105.00 Buy 1.05
Deutsche Bank 102.00 Buy 1.05
Equinet 66.50 Hold --
Independent Research 81.00 Sell 1.05
Morgan Stanley -- Underweight --
Warburg Research 69.00 Hold 1.05
UBS 78.00 Neutral --
===
Year-earlier figures are as reported by the company.
(a) Including Royalties.
(b) Pre one-time items.
(c) Including anonymous estimates from one more analyst.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires